康乐药业 (832126.OC)

+ 收藏

现金流量表(康乐药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 290,344,734.41626,396,784.45388,803,009.23711,033,613.70233,300,169.51
 收到的税费返还(元) 15,963,066.3745,419,620.1033,835,677.1050,548,659.3924,637,212.82
 收到其他与经营活动有关的现金(元) 19,897,134.6738,969,087.6415,248,969.6120,936,499.463,192,661.00
 经营活动现金流入小计(元) 326,204,935.45710,785,492.19437,887,655.94782,518,772.55261,130,043.33
 购买商品、接受劳务支付的现金(元) 152,272,817.10483,141,068.26288,515,806.32275,081,037.6562,432,601.73
 支付给职工以及为职工支付的现金(元) 25,778,588.0444,722,103.3125,545,114.9543,102,471.0522,461,970.92
 支付的各项税费(元) 24,496,805.0445,179,291.2329,540,522.4837,591,962.6316,449,979.99
 支付其他与经营活动有关的现金(元) 38,450,937.7521,946,459.5012,235,440.4928,210,913.0516,435,395.95
 经营活动现金流出小计(元) 240,999,147.93594,988,922.30355,836,884.24383,986,384.38117,779,948.59
 经营活动产生的现金流量净额(元) 85,205,787.52115,796,569.8982,050,771.70398,532,388.17143,350,094.74
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) 78,368.88-395,512.87-487,238.66
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -323,584.5111,213.59--
 收到其他与投资活动有关的现金(元) 100,038,726.51100,581,713.54100,075,637.13202,244,397.13181,194,156.83
 投资活动现金流入小计(元) 100,117,095.39100,905,298.05100,482,363.59202,244,397.13181,681,395.49
 购建固定资产、无形资产和其他长期资产支付的现金(元) 7,682,131.8930,061,671.8121,864,491.3719,996,524.042,412,658.98
 投资支付的现金(元) ---15,000,000.00-
 取得子公司及其他营业单位支付的现金净额(元) ---17,550,000.0017,550,000.00
 支付其他与投资活动有关的现金(元) 625,670,053.2385,769,046.0085,717,045.00202,105,944.18193,530,736.96
 投资活动现金流出小计(元) 633,352,185.12115,830,717.81107,581,536.37254,652,468.22213,493,395.94
 投资活动产生的现金流量净额(元) -533,235,089.73-14,925,419.76-7,099,172.78-52,408,071.09-31,812,000.45
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ----654,863.00
 筹资活动现金流入小计(元) ----654,863.00
 分配股利、利润或偿付利息支付的现金(元) -39,100,000.00-39,100,000.0038,736,299.72
 筹资活动现金流出小计(元) -39,100,000.00-39,100,000.0038,736,299.72
 筹资活动产生的现金流量净额(元) --39,100,000.00--39,100,000.00-38,081,436.72
四、汇率变动对现金及现金等价物的影响(元) 5,750,264.756,482,812.6727,643,946.50-3,746,262.9116,377,903.96
五、现金及现金等价物净增加额(元) -442,279,037.4668,253,962.80102,595,545.42303,278,054.1789,834,561.53
 加:期初现金及现金等价物余额(元) 648,660,995.83580,407,033.03646,435,187.91277,128,978.86277,128,978.86
 期末现金及现金等价物余额(元) 206,381,958.37648,660,995.83749,030,733.33580,407,033.03366,963,540.39
补充资料:
 净利润(元) 69,330,753.18202,861,371.16137,558,598.33165,960,814.7964,856,424.87
 资产减值准备(元) -376,559.36-509,410.84-579,158.242,143,071.78-
 固定资产和投资性房地产折旧(元) 10,312,977.0621,090,325.457,387,842.6723,916,799.7311,554,919.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 10,312,977.0621,090,325.457,387,842.6723,916,799.7311,554,919.08
 无形资产摊销(元) 490,902.72751,787.28490,902.72945,944.45835,838.59
 处置固定资产、无形资产和其他长期资产的损失(元) --330,496.8110,818.43-34,807.05-
 固定资产报废损失(元) 238.2641,177.51-323,574.675,511.67-7,522.93
 公允价值变动损失(元) -506,075.41-897,857.87-173,920.35
 财务费用(元) --17,334,516.74--30,687,544.80-
 投资损失(元) -78,368.88-447,511.87-395,512.87787,019.21-313,318.31
 递延所得税(元) -22,685.3417,644.2586,873.73117,480.1762,294.46
  其中:递延所得税资产减少(元) -22,685.3476,411.6286,873.7361,233.4536,206.41
 递延所得税负债增加(元) --58,767.37-56,246.7226,088.05
 存货的减少(元) -14,072,058.3310,854,550.67-6,212,902.84-26,027,789.94-19,005,411.67
 经营性应收项目的减少(元) 3,819,266.5715,671,110.538,269,661.59-11,915,929.54-15,938,884.84
 经营性应付项目的增加(元) 15,801,321.64-117,375,536.11-64,242,777.15272,423,959.83100,856,149.40
 现金的期末余额(元) 206,381,958.37648,660,995.83749,030,733.33580,407,033.03366,963,540.39
 减:现金的期初余额(元) 648,660,995.83580,407,033.03646,435,187.91277,128,978.86277,128,978.86
 现金及现金等价物的净增加额(元) -442,279,037.4668,253,962.80102,595,545.42303,278,054.1789,834,561.53
公告日期 2024-08-162024-04-192023-08-182023-04-192022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院